Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.3M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
25.1M
-
Shares change
-
-1.72M
-
Total reported value, excl. options
-
$86.3M
-
Value change
-
-$5.57M
-
Put/Call ratio
-
4.24
-
Number of buys
-
26
-
Number of sells
-
-38
-
Price
-
$3.44
Significant Holders of ENZO BIOCHEM INC - Common Stock (ENZB) as of Q1 2021
91 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock as of Q1 2021.
ENZO BIOCHEM INC - Common Stock (ENZB) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.1M shares
of 52.3M outstanding shares and own 47.98% of the company stock.
Largest 10 shareholders include HARBERT FUND ADVISORS, INC. (5.18M shares), BlackRock Inc. (3.91M shares), RENAISSANCE TECHNOLOGIES LLC (3.34M shares), Roumell Asset Management, LLC (2.74M shares), Evermore Global Advisors, LLC (2.61M shares), DIMENSIONAL FUND ADVISORS LP (1.63M shares), STATE STREET CORP (798K shares), GEODE CAPITAL MANAGEMENT, LLC (660K shares), NORTHERN TRUST CORP (457K shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (259K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.